Fus depleted oligodendrocytes reduce neuronal damage and attenuate AD progression in the AppNL-G-F mouse.

Saved in:
Bibliographic Details
Title: Fus depleted oligodendrocytes reduce neuronal damage and attenuate AD progression in the AppNL-G-F mouse.
Authors: Tung TH; Pittsburgh Institute for Neurodegenerative Diseases, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15206, USA., Babu S; Department of Neurobiology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15206, USA., Tang X; Pittsburgh Institute for Neurodegenerative Diseases, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15206, USA., Sciutto A; Pittsburgh Institute for Neurodegenerative Diseases, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15206, USA., Romer M; Children Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA., Racha P; Pittsburgh Institute for Neurodegenerative Diseases, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15206, USA., Fisler V; Pittsburgh Institute for Neurodegenerative Diseases, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15206, USA., Saha A; Department of Neurobiology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15206, USA., Saito T; Department of Neurocognitive Science, Institute of Brain Science, Nagoya City University, Nagoya, Aichi, Japan., Saido TC; Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako-shi, Saitama, Japan., Grinspan JB; Children Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA., Mathys H; Department of Neurobiology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15206, USA., Kozai TDY; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15213, USA.; Center for the Neural Basis of Cognition, University of Pittsburgh and Carnegie Mellon University, Pittsburgh, PA, United States of America.; Center for Neuroscience, University of Pittsburgh, Pittsburgh, PA, United States of America.; McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA, United States of America.; Neuroscience Institute, Carnegie Mellon University, Pittsburgh PA, United States of America., Cambi F; Pittsburgh Institute for Neurodegenerative Diseases, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15206, USA.; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15213, USA.; Veterans Administration Pittsburgh, Pittsburgh, PA, 15213, USA.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 Nov 26. Date of Electronic Publication: 2025 Nov 26.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.1101/2025.11.24.689041